Healthy Skepticism Library item: 8538

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Feldmann EG.
Preclearance of drug products--pharmacy's perspective.
Am Pharm 1981 Jun; NS21:(6):26-32

Abstract:

The problems arising from the recent challenges to the legal authority of the Food and Drug Administration to require premarketing approval for all drug products and their effects on pharmacy practice are discussed. The effects of the marketing of unapproved generics on drug quality assurance and the problems created by the pharmacist’s lack of information on the drugs granted FDA approval regarding drug product selection are discussed. Furnishing the pharmacists with listings of unapproved drugs and identifying FDA approval on the labels of prescription drugs provided to the pharmacists are some suggestions given to insure that only quality drugs are dispensed to patients.

Keywords:
Legislation, Drug Pharmaceutical Preparations/standards* Pharmacy* United States United States Food and Drug Administration